Rubin Marc Insider Trading Activity

Average Profitability
18.75%
Insider Buys Quantity
14
Insider Buys Sum
$503,071.70
Insider Sells Quantity
5
Insider Sells Sum
$759,245.41

Insider Activity of Rubin Marc

Biography of Rubin Marc

No biography is available at this moment.

2019-02-22SaleGalectin Therapeutics Inc.
GALT
director
859
0.002%
$6.02$5,175-31.62%
2019-02-21SaleGalectin Therapeutics Inc.
GALT
director
50,326
0.1119%
$6.02$303,026-35.96%
2019-01-23SaleCuris, Inc.
CRIS
director
18,500
0.0549%
$1.05$19,477+68.22%
2018-09-04SaleGalectin Therapeutics Inc.
GALT
director
11,900
0.0292%
$6.58$78,256-29.2%
2018-08-30SaleGalectin Therapeutics Inc.
GALT
director
58,100
0.1473%
$6.08$353,312-20.65%
2017-12-08PurchaseGalectin Therapeutics Inc.
GALT
director
14,000
0.0301%
$1.85$25,943+95.68%
2017-11-16PurchaseCuris, Inc.
CRIS
director
25,000
0.0176%
$0.98$24,500-47.17%
2013-12-04PurchaseGalectin Therapeutics Inc.
GALT
director
6,000
0.0357%
$8.69$52,140+30.03%
2011-10-18PurchaseGalectin Therapeutics Inc.
GALT
director
40,000
0.055%
$0.96$38,400-47.08%
2010-12-10PurchaseCuris, Inc.
CRIS
director
26,596
0.0355%
$1.89$50,266+73.55%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.